The label ‘Chronic Fatigue Syndrome’ was first proposed by…
““The label ‘Chronic Fatigue Syndrome’ was first proposed by Holmes et al. (1988) of the Centers for Disease Control (CDC). This name was recommended to replace that of a number of terms that implied a causal pathology (e.g. ‘Myalgic Encephalomyelitis’, ‘Post-Viral Fatigue Syndrome’ and ‘chronic Epstein-Barr virus syndrome’), as there was a lack of correlation between biological markers and symptomatology. Hence, this new label reflected the prime clinical characteristic of the condition without alluding to an underlying physical aetiology and, in turn, the definition was based upon signs and symptoms of the patient group. However, many individuals use the term Myalgic Encephalomyelitis (indicating muscle pain and inflammation of the brain), a fact that is reflected by the titles of the two largest charitable organisations in the UK, the ME Association and Action for ME.””
About This Quote
This interpretation was drafted with AI assistance. It is one reading of the quote, not the author's own explanation.
A neutral label focuses on observable symptoms, avoiding unproven causal assumptions.
In simple terms: Use symptom‑based naming to reduce stigma.
Key Takeaway
Prioritize clear, evidence‑based terminology.
Themes
medical terminology
stigma
clinical communication
Mood
analytical
empathetic
Type
clinical
educational
When to use this quote
- clinical documentation
- patient education
- policy drafting
Key Concepts
Diagnostic clarity
patient advocacy
Questions to Reflect On
- How does naming affect patient experience?
- Should labels evolve with scientific understanding?
A Different Perspective
May not capture underlying causes, limiting research focus.